I don't think I've ever replied to any of your posts

New Post Public Reply Private Reply Replies (0) Message Board
HCIT craigakess #109679
631
I don't think I've ever replied to any of your posts because they have an unusual slant on things and most here take that with a grain of salt or just ignore as you are a very different type of poster on Hangouts but anyway, here is your quote:

Craiga, your quote:
Response: NO, it isn't showing "incredible performance", it is showing a PRELUDE to what we hope will be an incredible performance. Promising NASH results with only 5 people and cancer with only two dozen is a FANTASTIC start, don't get me wrong. But that doesn't mean that Vyrologix has proven itself to be a world beater in those areas just yet.

The street has not seen CYDY start and complete anything yet to the point where anyone is taking notice but us and a small handful of others. If further results in NASH and cancer (and hopefully covid in Brazil) continue as we think they will, THEN we will have something that moves our share price forward. Steady as she goes.

ME:
I know CYDY is spread out in indications like a slice of bread with butter and I understand the exactness of your post. You are correct in that CYDY has not yet put anything across the approval or EUA line in the sand to claim a victory. But, they have started an arsenal of trials/indications that are ever so slowly showing efficacy, (safety is proven already in Leronlimab), and some preliminary results but the company is preparing it's future that WHEN, only one of them proves efficacy, that arsenal will become armed and ready to fire away over a period of time, approvals, and if the pandemic still hasn't subsided, an EUA or two & I think the BOD's and all those involved in all of these indications know this and are doing just that above, preparing their arsenal to go off like one after one and over that period, we will see more successes in light of their preparation over the last year or so.

So yes, the company is showing "incredible performance" to date in their forward progress of bring all these indications to the top like cream at the top in that respective analogy and yes again, it is showing a prelude to what has yet to come.

Craiga, your slant on things I now understand in that you say prove it, and I get it, they've not proven anything but you have to believe, ( and I know you do), that it surely is coming, only if forces that don't want Leronlimab to come forth will give it some breathing room - GLTU

HCIT

re:edited: I hope my friendly and favorite positive posters here don't give me thumbs down for this reply to Craigakess but he/she does prove a point in a very different perspective in what we all want to hear so please don't kill me in thumbs down and again, GLTA of us as you all know I'm a very long investor for a very long time and longer than most and still haven't sold 1/2 of 1 share

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
https://media.gettyimages.com/photos/the-grea...wdoE_swYM=
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Bond Fund Investors Alert: Legal Action Ahead

Updated Category News Views 144

Critical Alert for Investors in Easterly ROCMuni Bond Fund Attention investors! There’s an important deadline approaching concerning legal actions related to the Easterly ROCMuni High Income Municipal Bond Fund. If you have experienced losses, now is the time to stay informed and act. Understanding the Situation Recently, the Easterly ROCMuni High Income Municipal Bond...

Continue Reading
Veralto Declares Consistent Quarterly Dividend for Investors

Updated Category News Views 51

Veralto's Quarterly Dividend Announcement Veralto (NYSE: VLTO), a leading name in water and product quality solutions, has announced a quarterly dividend of $0.09 per share. This decision underscores Veralto's unwavering commitment to its shareholders and its ongoing financial health. Understanding Dividend Payments Dividends often indicate a company's financial...

Continue Reading
BioLineRx Sees Growth in Pipeline and Financial Resilience

Updated Category News Views 133

BioLineRx Continues to Build Momentum with Financial Stability BioLineRx Ltd. (NASDAQ: BLRX), a prominent biopharmaceutical company dedicated to advancing treatments in oncology and rare diseases, has reported robust financial results and significant progress in its operational endeavors. The company is pursuing new innovative avenues for pipeline expansion while ensuring...

Continue Reading
Blues Expands Partner Network to Enhance IoT Solutions

Updated Category News Views 35

Blues Expands Its Partnership Network Recently, the Blues Partner Network has marked a significant milestone by welcoming more than fifty accredited partners. This innovative initiative focuses on easing the connections between sensors and the analytics solutions essential for various businesses. The advantages brought by Blues' products streamline how devices connect to...

Continue Reading
Lamarr.AI Secures $1.1 Million to Enhance Building Solutions

Updated Category News Views 57

Lamarr.AI Secures $1.1 Million to Improve Building Solutions Lamarr.AI has recently garnered substantial attention, raising $1.1 million in a pre-seed funding round aimed at advancing their innovative building diagnostics technology. Supported by notable investors, including Hazelview Ventures, milemark·capital, and Newlab, Lamarr.AI is positioning itself as a leader in...

Continue Reading